Chief Technical Officer
Andrew has more than 25 years of experience in biotechnology manufacturing and supply chain operations. Prior to joining Cirius, Andrew was chief technical officer and senior vice president technical operations at AveXis Inc., which was acquired by Novartis, where he played a critical role in building a team to support commercial scale manufacturing and approval of a gene therapy. Prior to AveXis, Andrew held numerous manufacturing and operations executive positions at Amgen, Hospira and Novartis. He received a B.S. in biological sciences, health and secondary education from Concordia University, an M.S. in cell biology and genetics from the University of Nebraska and an M.B.A. from The Anderson School of Management at U.C.L.A.